Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells: a possible link to pan-coronary syndromes.
Valgimigli M, Agnoletti L, Curello S, Comini L, Francolini G, Mastrorilli F, Merli E, Pirani R, Guardigli G, Grigolato PG, Ferrari R. Valgimigli M, et al. Among authors: guardigli g. Circulation. 2003 Jan 21;107(2):264-70. doi: 10.1161/01.cir.0000045665.57256.86. Circulation. 2003. PMID: 12538426 Clinical Trial.
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study.
Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, Cicchitelli G, Olivares A, Parrinello G, Percoco G, Guardigli G, Mele D, Pirani R, Ferrari R. Valgimigli M, et al. Among authors: guardigli g. Circulation. 2005 Feb 22;111(7):863-70. doi: 10.1161/01.CIR.0000155614.35441.69. Epub 2005 Feb 7. Circulation. 2005. PMID: 15699251
Oxidative stress during myocardial ischaemia and heart failure.
Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S. Ferrari R, et al. Among authors: guardigli g. Curr Pharm Des. 2004;10(14):1699-711. doi: 10.2174/1381612043384718. Curr Pharm Des. 2004. PMID: 15134567 Review.
Ferrara II.
Ferrari R, Guardigli G. Ferrari R, et al. Among authors: guardigli g. Eur Heart J. 2017 Dec 1;38(45):3337-3339. doi: 10.1093/eurheartj/ehx675. Eur Heart J. 2017. PMID: 29206967 No abstract available.
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial.
Valgimigli M, Percoco G, Barbieri D, Ferrari F, Guardigli G, Parrinello G, Soukhomovskaia O, Ferrari R. Valgimigli M, et al. Among authors: guardigli g. J Am Coll Cardiol. 2004 Jul 7;44(1):14-9. doi: 10.1016/j.jacc.2004.03.042. J Am Coll Cardiol. 2004. PMID: 15234398 Free article. Clinical Trial.
A modern fairy tale.
Ferrari R, Guardigli G, Tavazzi L. Ferrari R, et al. Among authors: guardigli g. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S65-7. doi: 10.1097/01.hjr.0000359241.90303.37. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19675442 No abstract available.
Ferrara VI.
Ferrari R, Guardigli G, Cimaglia P. Ferrari R, et al. Among authors: guardigli g. Eur Heart J. 2018 May 1;39(17):1509-1511. doi: 10.1093/eurheartj/ehy180. Eur Heart J. 2018. PMID: 29718350 No abstract available.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
68 results